Browse medicines, page 31 of 150

Use listed on the medicine record

Reduced strength, energy, or stamina

Use listed on the medicine record

• EMPLICITI is indicated in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received one to three prior therapies. • EMPLICITI is indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor.

Use listed on the medicine record

ELREXFIO is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This indication is approved under accelerated approval based on response rate and durability of response [see Clinical Studies (14) ] . Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).

Use listed on the medicine record

Post-exposure prophylaxis of coronavirus disease 2019

Use listed on the medicine record

For temporary relief of minor: frequent urination* bladder discomfort* backache* swollen ankles and feet* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

For temporary relief of minor: nervous irritability* exhaustion* worry* neck and back tension* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

INDICATIONS & USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Use listed on the medicine record

Esophageal varices that have recently bled, to prevent rebleeding

Use listed on the medicine record

Etoposide Injection, USP is indicated in the management of the following neoplasms: Refractory Testicular Tumors Etoposide Injection, USP in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. Adequate data on the use of etoposide capsules in the treatment of testicular cancer are not available.

Use listed on the medicine record

WASKYRA ® is indicated for the treatment of pediatric patients aged 6 months and older and adults with Wiskott-Aldrich Syndrome (WAS) who have a mutation in the WAS gene and for whom hematopoietic stem cell transplantation (HSCT) is appropriate and no suitable human leukocyte antigen (HLA)-matched related stem cell donor is available.

Use listed on the medicine record

INDICATIONS: Aids in temporary relief of symptoms associated with exposure to biological toxins such as headaches, fatigue, runny nose, irritability and achy muscles or joints.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

Allergies

Use listed on the medicine record

INDICATIONS: May temporarily relieve symptoms associated with tree sensitivities, such as congestion and runny nose and sneezing.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evalutated.

Use listed on the medicine record

The treatment of patients

Use listed on the medicine record

NE Lotion Indications

Use listed on the medicine record

Studies have shown that skin tests with cat extract are useful in the diagnosis of cat allergy. As a rule, persons with cat allergy have positive skin reactions when tested with cat extract, and non-allergic individuals rarely react (7, 8, 9). However, the relationship between a positive skin test and the appearance of clinical symptoms after exposure to a cat is not absolute, i.e., some skin-test positive persons do not experience allergic symptoms after exposure (10).

Use listed on the medicine record

INDICATIONS Allergies.

Use listed on the medicine record

INDICATIONS For the temporary relief of fatigue, weakness, exhaustion, flushed skin, muscle twitches, shortness of breath, trouble concentrating, occasional headache, or feelings of discomfort or uneasiness.*

Use listed on the medicine record

Overactive bladder

Use listed on the medicine record

For temporary relief of minor: congestion* coughing* itchiness* wheezing* sinus discomfort* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

Symptoms associated with laryngitis and voice hoarseness

Use listed on the medicine record

AJOVY is indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more. AJOVY is a calcitonin gene-related peptide antagonist indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more. ( 1 )

Use listed on the medicine record

Magnetic resonance imaging (MRI) of the liver to detect and characterize lesions

Use listed on the medicine record

Episodic cluster headache

Use listed on the medicine record

Positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions

Use listed on the medicine record

Temporarily relieves allergy symptoms associated with exposure to hair, feathers, dander, and/or epithelia from animals.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Use listed on the medicine record

Mild skin rash, itchy skin, changes in urination, chills, joint pain or body aches, nausea, or fatigue

Use listed on the medicine record

Symptoms associated with minor fever

Use listed on the medicine record

Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).

Use listed on the medicine record

COLUMVI is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell lymphoma (LBCL) arising from follicular lymphoma, after two or more lines of systemic therapy. This indication is approved under accelerated approval based on response rate and durability of response [see Clinical Studies (14.1) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Use listed on the medicine record

Toxic plasma methotrexate concentration